Peptide quality control testing should be planned around the material’s intended research use and the attributes the receiving team needs to verify. A single purity percentage may be useful, but it does not automatically establish identity, absolute content, counter-ion composition, residual solvents or every other property of a peptide sample. Buyers should agree on the analytical scope before production so the supplier can quote the correct work and report the expected results.
SciLight Biotechnology provides project-specific peptide characterization and analytical services. This guide outlines the main elements to consider when preparing a research peptide quality specification.
Define the quality questions first
Start by identifying what your team needs to know about the peptide. Is the central question whether the expected molecule was produced? Does the project require a chromatographic purity result? Is absolute content important for preparing a defined concentration? Are there specific impurity or material-form concerns? Different questions require different analytical methods, and not every project needs every possible test.
Identity and molecular characterization
State how identity should be assessed and what reference structure will be used. Mass-based characterization can support identity assessment, while sequence and modification details are needed to interpret the expected result correctly. If the material includes a label, linker, cyclic structure or non-standard residue, include it in the reference information.
Purity and impurity assessment
Specify the purity target and the reporting method. Chromatographic area percentage is a method-dependent measure and should not automatically be interpreted as weight percentage or absolute content. Ask what impurities are included in the reported calculation and whether the analytical method is appropriate for the sample.
Content, counter-ion and other attributes
Depending on the application, the project may need information beyond identity and chromatographic purity. For medicinal-product development, the European Medicines Agency’s synthetic peptide guideline discusses tests such as content, counter-ion identity, water, residual solvents and impurities as relevant specification considerations. That guideline applies to development and manufacture of synthetic peptides for medicinal-product contexts; it should not be copied as a universal checklist for every research peptide. See the EMA guideline.
What should a peptide analytical report contain?
Agree on the sample identifier, test method, date or batch reference, results, acceptance criteria if applicable and any relevant method limitations. Confirm whether chromatograms, mass spectra or other supporting data are included, and whether the supplier will provide a formal certificate or a technical report. Do not assume every supplier uses the same report format.
How to specify quality testing in an RFQ
- Attach the exact peptide sequence and all modifications.
- State target purity and any identity requirements.
- List additional tests required for your application.
- Identify report format, batch identification and documentation needs.
- Ask which tests are included in the quotation and which are optional.
Request peptide quality characterization
Send your sequence, intended research context, quantity, purity target and documentation requirements through SciLight’s quotation form. You can also review quality assurance information and the analytical services page.
Quality specifications must match the actual application and applicable requirements. This article is for scientific procurement and is not regulatory or medical advice.